Wearable electric field therapy slows aggressive breast cancer, study finds
Wearable electric field therapy slows aggressive breast cancer, study finds The Brighter Side of News
Онкология
Рак молочной железы
677 материалов по теме, собраны автоматически из проверенных источников
🎗️
Онкология
AstraZeneca’s Etcamah flunks first-line breast cancer trial, adding to oral SERDs’ failure record
AstraZeneca’s Etcamah flunks first-line breast cancer trial, adding to oral SERDs’ failure record Fierce Pharma
Онкология
AI virtual cell uses protein dynamics to predict personalized breast cancer treatments
Not all cancer cells are the same, and neither are their responses to drugs. Finding the right drug for the right cancer cell is a long battle in drug development and in designing effective treatments. A new AI tool called ProteinTalks makes this task easier by accurately predicting whether a drug will be effective…
🎗️
Онкология
Advanced Breast Cancer Drug Fails Key Clinical Trial Days After Regulatory Approval
Advanced Breast Cancer Drug Fails Key Clinical Trial Days After Regulatory Approval ndtv.com
Онкология
Breast cancer pill from AstraZeneca misses mark in pivotal trial
Breast cancer pill from AstraZeneca misses mark in pivotal trial STAT
Онкология
SERENA-4 Phase III Trial Misses Primary PFS Endpoint for Camizestrant Plus Palbociclib in First-Line Advanced Breast Cancer
SERENA-4 Phase III Trial Misses Primary PFS Endpoint for Camizestrant Plus Palbociclib in First-Line Advanced Breast Cancer Oncodaily
🎗️
Онкология
AstraZeneca’s breast cancer drug fails in late-stage trial
AstraZeneca’s breast cancer drug fails in late-stage trial WTVB
Онкология
Breast Cancer Research Results: Challenges in Combining Focused Ultrasound with Immunotherapy | Newswise
Breast Cancer Research Results: Challenges in Combining Focused Ultrasound with Immunotherapy | Newswise Newswise
🎗️
Онкология
AstraZeneca's breast cancer pill fails in late-stage trial
AstraZeneca's breast cancer pill fails in late-stage trial reuters.com
🎗️
Онкология
AstraZeneca's Etcamah fails in late-stage trial as first-line breast cancer treatment
AstraZeneca's Etcamah fails in late-stage trial as first-line breast cancer treatment Seeking Alpha
🎗️
Онкология
AstraZeneca’s SERD Etcamah Fails in Phase III First-Line Breast Cancer Trial
AstraZeneca’s SERD Etcamah Fails in Phase III First-Line Breast Cancer Trial GenomeWeb
Онкология
UNC Study Develops Data-Driven Tool to Help Oncologists Identify High-Risk Periods for Metastatic Breast Cancer Patients
UNC Study Develops Data-Driven Tool to Help Oncologists Identify High-Risk Periods for Metastatic Breast Cancer Patients UNC Health
🎗️
Онкология
AstraZeneca breast cancer drug fails late-stage trial goal
AstraZeneca breast cancer drug fails late-stage trial goal Investing.com
Онкология
AstraZeneca's breast cancer drug fails in late-stage trial
AstraZeneca's breast cancer drug fails in late-stage trial KSL
🎗️
Онкология
Update on SERENA-4 Phase III trial of Etcamah in combination with palbociclib in upfront 1st-line advanced ER-positive breast cancer
Update on SERENA-4 Phase III trial of Etcamah in combination with palbociclib in upfront 1st-line advanced ER-positive breast cancer AstraZeneca